Marc R. Sarni, Director at HOLLIS EDEN PHARMACEUTICALS INC /DE/ (HEPH), bought 5,000 shares at $5.40 ($27K) on 2006-12-08, disclosed to the SEC on 2006-12-11.
Open-market purchase of $27k HEPH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.